Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma. - Liu Z; Rao M; Poiret T; Nava S; Meng Q; von Landenberg A; Bartek J Jr; Xie S; Sinclair G; Peredo I; Dodoo E; Maeurer M (Oncotarget, 2017)